BACKGROUND: Reports show higher prevalence of albuminuria among Hispanics compared with whites. Differences by country of origin or genetic background are unknown. METHODS AND RESULTS: In Multi-Ethnic Study of Atherosclerosis, we studied the associations of both genetic ancestry and country of origin with albumin to creatinine ratio among 1417 Hispanic versus white participants using multivariable linear regression and back transforming beta coefficients into relative difference (%RD, 95% CI). Percentage European, Native American, and African ancestry components for Hispanics were estimated using genetic admixture analysis. The proportions of European, Native American, and African genetic ancestry differed significantly by country of origin (P<0.0001); Mexican/Central Americans had the highest Native American (41+/-13%), Puerto Ricans had the highest European (61+/-15%), and Dominicans had the highest African (39+/-21%) ancestry. Hispanic ethnicity was associated with higher albumin/creatinine ratio compared with whites, but the association varied with the country of origin (adjusted P interaction=0.04). Mexican/Central Americans and Dominicans had higher albumin/creatinine ratio compared with whites after adjustment (RD 19%, 2% to 40% and RD 27%, 1% to 61%), but not Puerto Ricans (RD 8%, -12% to 34%). Higher Native American ancestry was associated with higher albuminuria after age and sex adjustment among all Hispanics (RD 11%, 1% to 21%) but was attenuated after further adjustment. Higher European ancestry was independently associated with lower albumin/creatinine ratio among Puerto Ricans (-21%, -34% to -6%) but not among Mexican/Central Americans and Dominicans. CONCLUSIONS: Hispanics are a heterogeneous group with varying genetic ancestry. Risks of albuminuria differ across the country of origin groups. These differences may be due, in part, to differences in genetic ancestral components.
BACKGROUND: Reports show higher prevalence of albuminuria among Hispanics compared with whites. Differences by country of origin or genetic background are unknown. METHODS AND RESULTS: In Multi-Ethnic Study of Atherosclerosis, we studied the associations of both genetic ancestry and country of origin with albumin to creatinine ratio among 1417 Hispanic versus white participants using multivariable linear regression and back transforming beta coefficients into relative difference (%RD, 95% CI). Percentage European, Native American, and African ancestry components for Hispanics were estimated using genetic admixture analysis. The proportions of European, Native American, and African genetic ancestry differed significantly by country of origin (P<0.0001); Mexican/Central Americans had the highest Native American (41+/-13%), Puerto Ricans had the highest European (61+/-15%), and Dominicans had the highest African (39+/-21%) ancestry. Hispanic ethnicity was associated with higher albumin/creatinine ratio compared with whites, but the association varied with the country of origin (adjusted P interaction=0.04). Mexican/Central Americans and Dominicans had higher albumin/creatinine ratio compared with whites after adjustment (RD 19%, 2% to 40% and RD 27%, 1% to 61%), but not Puerto Ricans (RD 8%, -12% to 34%). Higher Native American ancestry was associated with higher albuminuria after age and sex adjustment among all Hispanics (RD 11%, 1% to 21%) but was attenuated after further adjustment. Higher European ancestry was independently associated with lower albumin/creatinine ratio among Puerto Ricans (-21%, -34% to -6%) but not among Mexican/Central Americans and Dominicans. CONCLUSIONS: Hispanics are a heterogeneous group with varying genetic ancestry. Risks of albuminuria differ across the country of origin groups. These differences may be due, in part, to differences in genetic ancestral components.
Authors: Heather E Collins-Schramm; Bill Chima; Takanobu Morii; Kimberly Wah; Yolanda Figueroa; Lindsey A Criswell; Robert L Hanson; William C Knowler; Gabriel Silva; John W Belmont; Michael F Seldin Journal: Hum Genet Date: 2003-11-20 Impact factor: 4.132
Authors: C Bonilla; E J Parra; C L Pfaff; S Dios; J A Marshall; R F Hamman; R E Ferrell; C L Hoggart; P M McKeigue; M D Shriver Journal: Ann Hum Genet Date: 2004-03 Impact factor: 1.670
Authors: Esteban González Burchard; Pedro C Avila; Sylvette Nazario; Jesus Casal; Alfonso Torres; Jose R Rodriguez-Santana; Monica Toscano; Jody Senter Sylvia; MariaElena Alioto; Michael Salazar; Ivan Gomez; Joanne K Fagan; Jorge Salas; Craig Lilly; Henry Matallana; Elad Ziv; Richard Castro; Moises Selman; Rocio Chapela; Dean Sheppard; Scott T Weiss; Jean G Ford; Homer A Boushey; William Rodriguez-Cintron; Jeffrey M Drazen; Edwin K Silverman Journal: Am J Respir Crit Care Med Date: 2003-11-14 Impact factor: 21.405
Authors: Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan Journal: Ann Intern Med Date: 2003-07-15 Impact factor: 25.391
Authors: Katherine L Ender; Margaret T Lee; Sujit Sheth; Maureen Licursi; Jennifer Crotty; Sandra Barral; Nancy S Green Journal: J Pediatr Hematol Oncol Date: 2011-10 Impact factor: 1.289
Authors: Erica Chan Day; Yongmei Li; Ana Diez-Roux; Namratha Kandula; Andrew Moran; Sylvia Rosas; Michael G Shlipak; Carmen A Peralta Journal: Nephrol Dial Transplant Date: 2010-11-04 Impact factor: 5.992
Authors: Miriam S Udler; Girish N Nadkarni; Gillian Belbin; Vaneet Lotay; Christina Wyatt; Omri Gottesman; Erwin P Bottinger; Eimear E Kenny; Inga Peter Journal: J Am Soc Nephrol Date: 2014-10-27 Impact factor: 10.121
Authors: Carmen A Peralta; Ronit Katz; Ian DeBoer; Joachim Ix; Mark Sarnak; Holly Kramer; David Siscovick; Steven Shea; Moyses Szklo; Michael Shlipak Journal: J Am Soc Nephrol Date: 2011-06-23 Impact factor: 10.121
Authors: Michael J Fischer; Alan S Go; Claudia M Lora; Lynn Ackerson; Janet Cohan; John W Kusek; Alejandro Mercado; Akinlolu Ojo; Ana C Ricardo; Leigh K Rosen; Kaixiang Tao; Dawei Xie; Harold I Feldman; James P Lash Journal: Am J Kidney Dis Date: 2011-06-25 Impact factor: 8.860
Authors: Cristina M Arce; Aya A Mitani; Benjamin A Goldstein; Wolfgang C Winkelmayer Journal: Clin J Am Soc Nephrol Date: 2011-11-23 Impact factor: 8.237
Authors: William M McClellan; David G Warnock; Suzanne Judd; Paul Muntner; Reshma Kewalramani; Mary Cushman; Leslie A McClure; Britt B Newsome; George Howard Journal: J Am Soc Nephrol Date: 2011-08-25 Impact factor: 10.121
Authors: Jeffrey N Weitzel; Jessica Clague; Arelis Martir-Negron; Raquel Ogaz; Josef Herzog; Charité Ricker; Chelsy Jungbluth; Cheryl Cina; Paul Duncan; Gary Unzeitig; J Salvador Saldivar; Mary Beattie; Nancy Feldman; Sharon Sand; Danielle Port; Deborah I Barragan; Esther M John; Susan L Neuhausen; Garrett P Larson Journal: J Clin Oncol Date: 2012-12-10 Impact factor: 44.544